ArticleBMC plant biology2025
An enhanced gene function analysis platform for Gastrodia Elata integrating further omics data and analysis tools.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent advances inFrontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gastrodia elata, the dried tuber of the Gastrodia orchid, is a valued traditional Chinese medicine with important medicinal and dietary benefits. The growing multi-omics data demands an updated platform to include the latest G.elata genome and transcriptome, thereby enhancing gene function analysis for researchers. In this study, we built co-expression network using four versions of the G.elata genome, incorporated the latest transcriptome data, and annotated genes with sequences from TAIR, Uniprot, NR, and Swisprot databases. GO and KEGG annotations were predicted using InterProScan and GhostKOALA, while gene families were identified with HMMER, iTAK, OrthoFinder, and KEGG annotations. We further completed the GelFAP v3.0 upgrade ( http://www.gzybioinformatics.cn/Gelv3 ), integrating results and adding tools like BLAST, Gene sets enrichment analysis, Extract sequence, JBrowse v2, multiple sequence alignment, DEG analysis, DEM analysis, primer design and heatmap analysis. Through this platform, we identified that the GeMYB4 gene may function as a potential suppressor of flavonoid biosynthesis. Additionally, the platform enabled the identification of GePAL1, a key gene in the phenylpropanoid pathway, which showed higher expression in G.elata f.glauca compared to f.elata and was co-expressed with other upregulated genes involved in phenolic compound biosynthesis. Using GeMYB4 and GePAL1 as cases, we demonstrate the utility of this platform. GelFAP v3.0 will aid in analyzing key genes related to the biosynthesis of secondary metabolites, stress response, growth and development, offering researchers enhanced resources for studying G.elata gene functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.